Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
Shinsuke SuzukiTakashi AkiyoshiKoji ObaFuhito OtsukaTetsuro TominagaToshiya NagasakiYosuke FukunagaMasashi UenoPublished in: Annals of surgical oncology (2019)
LCR may be the most useful predictive factor for OS and DFS in patients with stage II or III colon cancer.
Keyphrases